Long‐Term Clinical Outcomes of Balloon‐Expandable Versus Self‐Expanding Transcatheter Aortic Valve Replacement in Patients With Small Aortic Annulus
Open Access
- 6 January 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (1) , e045417
Abstract
Background: Self‐expanding valves (SEVs) have demonstrated superior hemodynamic performance and comparable clinical outcomes to balloon‐expandable valves (BEVs) at 1 year in patients with a small aortic annulus. However, long‐term data are limited. This study aimed to evaluate 5‐year echocardiographic and clinical outcomes of SEVs versus BEVs in patients with small aortic annulus underwent transcatheter aortic valve replacement. Methods: We analyzed RESOLVE registry patients who underwent transcatheter aortic valve replacement at Cedars‐Sinai between 2015 and 2020. Patients with a small aortic annulus (2 by computed tomography) were included and followed for up to 5 years. The primary outcome was a composite of all‐cause mortality, stroke, or heart failure hospitalization. Secondary outcomes included myocardial infarction, pacemaker implantation, aortic valve reintervention, and structural bioprosthetic valve dysfunction. Results: Among 1392 transcatheter aortic valve replacement recipients, 423 (78 SEVs, 345 BEVs) met the small annulus criteria. SEVs were associated with lower transvalvular gradients and larger indexed effective orifice area at discharge and 1 year ( P P P P <0.33). All‐cause mortality, stroke, heart failure hospitalization, structural bioprosthetic valve dysfunction, and reintervention rates were similar between groups. Conclusion: Although SEVs provide better hemodynamic performance in patients with severe aortic stenosis and small annuli, this advantage did not translate into improved survival or reduced cardiovascular events at 5 years.Keywords
This publication has 29 references indexed in Scilit:
- Long-Term Outcomes of Patients Requiring Pacemaker Implantation After Transcatheter Aortic Valve ReplacementJACC: Cardiovascular Interventions, 2025
- 5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic StenosisJACC, 2025
- Transcatheter Aortic Valve Implantation by Valve Type in Women With Small AnnuliJAMA Cardiology, 2024
- Evolut PRO and SAPIEN ULTRA Performance in Small Aortic AnnuliJACC: Cardiovascular Interventions, 2024
- Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Implantation in Patients With Small Aortic Annulus: A Meta-AnalysisThe American Journal of Cardiology, 2023
- Echocardiographic Versus Invasive Aortic Valve Gradients in Different Clinical ScenariosJournal of the American Society of Echocardiography, 2023
- Transcatheter Aortic Valve Replacement With the Latest-Iteration Self-Expanding or Balloon-Expandable ValvesJACC: Cardiovascular Interventions, 2022
- Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical ResearchJACC, 2021
- 5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding ValvesJACC: Cardiovascular Interventions, 2020
- Prosthesis-Patient Mismatch Following Transcatheter Aortic Valve Replacement With Supra-Annular and Intra-Annular ProsthesesJACC: Cardiovascular Interventions, 2019